Biotech Values

[exwannabe]

... let GILD tout their so called convenience.

I have to agree with the GILD camp that in 1A, naive, non-chirotic patients, GILD does have a real advantage.

That said, it seams to leave enough on the table to allow some serious profits for ABBV/ENTA.